Colossal Biosciences Acquires Viagen, the Leader in Animal Cloning
On Nov. 4, 2025, Colossal Biosciences, the world’s de-extinction company, today announced its acquisition of Viagen Pets and…
Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal
On Nov. 3, 2025, Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about…
CIRM awards $27 million to launch novel program designed to bring cell and gene therapies to underserved California communities
On Oct. 30, 2025, the California Institute for Regenerative Medicine (CIRM) approved awarding $27 million through three grants…
St. Jude calculators crunch the numbers to empower survivors of childhood cancer
On Oct. 7, 2025, St. Jude announced that it hosts multiple freely accessible Medical Risk Calculators on the…
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion
On Oct. 29, 2025, Thermo Fisher announced it would buy privately held data management company Clario for up…
Lilly announces $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the U.S.
On Oct. 29, 2025, Eli Lilly announced a planned investment of more than $1.2 billion to expand and…
Phage G genome: AI analysis maps out world’s largest cultivated bacteria-killing virus
On Oct. 29, 2025, University of North Carolina at Charlotte (UNC) researchers leading a multidisciplinary team across four…
Rice launches Brain Institute to accelerate discoveries in brain science and health
On Oct. 29, 2025, Rice University announced the creation of the Rice Brain Institute (RBI), an ambitious, interdisciplinary…
Lilly partners with Nvidia on AI supercomputer to speed up drug development
On Oct. 28, 2025, Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer…
Louisiana officials waited months to warn public of whooping cough outbreak
On Oct. 28, 2025, The Louisiana Illuminator reported that when there’s an outbreak of a vaccine-preventable disease, state…
Qureator Achieves World’s First FDA IND Approval Using Only Human Vascularized Organoid Efficacy Data
On Oct. 27, 2025, Qureator announced a major milestone, confirming a fundamental shift in drug development under the…
New Hampshire Man resumes dialysis after living with a gene-edited pig kidney for a record 271 days
On Oct. 27, 2025, a New Hampshire man resumed dialysis after living with a gene-edited pig kidney for…
Novartis to acquire Avidity Biosciences, an innovator in RNA therapeutics for $11 Billion
On Oct. 26, 2025, Novartis announced that it has entered into an agreement to acquire Avidity Biosciences, a…
Study suggests two unsuspected pathogens struck Napoleon’s army during the retreat from Russia in 1812
On Oct. 24, 2025, scientists from the Institut Pasteur announced they have genetically analyzed the remains of former…
Lilly to Acquire Adverum Biotechnologies for $12.47 per Share
On Oct. 24, 2025, Eli Lilly and Adverum Biotechnologies announced a definitive agreement for Lilly to acquire Adverum,…
Measles Outbreak Continues growing in South Carolina among Unvaccinated
As of Oct. 24, 2025, the South Carolina Department of Public Health (DPH) reported 33 cases of measles…
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma
On Oct. 23, 2025, GSK announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf)…
Ancient DNA Database Faces Uncertain Future after Funding Expires
On Oct. 23, 2025, researchers at a Harvard Medical School laboratory announced they are uncertain how they will…
Biology | Cardiovascular | Diagnostics | Disease | Environmental | EPA | Neurology | Non-Profit Research | WHO | Women's Health
Nearly 9 in 10 air pollution deaths are from noncommunicable diseases
On. Oct. 23, 2025, Air pollution continues to exacerbate global health, including noncommunicable diseases and dementia, according to…
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology
On Oct. 23, 2025, CareDx announced the publication of the second study from Surveillance HeartCare Outcomes Registry (SHORE)…
Alkermes Announces Agreement to Acquire Avadel Pharmaceuticals for $2.1 billion
On Oct. 22, 2025, Alkermes and Avadel Pharmaceuticals announced the companies have entered into a definitive agreement under…
South Carolina Department of Public Health Confirms Measles Outbreak
On Oct. 22, 2025, the South Carolina Department of Public Health (SCDPH) announced it is actively responding to…
Pigs developed to be resistant to deadly virus
On Oct. 22, 2025, a Roslin Institute led team announced they have developed pigs that are resistant to…
Blackstone, and TPG announce plans to take medtech Hologic private for $18.3 billion
On Oct. 21, 2025, private equity firms Blackstone and TPG said they will buy medical diagnostics firm Hologic…
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine | Veterinary
Fall Migration brings increased risk of Highly Pathogenic Avian Influenza
On Oct. 21, 2025, the Oregon Department of Agriculture has warned that as wild birds begin to migrate…
CDC | NIH | U.S. Congress
NEJM and public health group are launching rival to CDC’s MMWR publication
On Oct. 21, 2025, in the latest bid to plug gaps in the federal government’s public health infrastructure,…
A seed bank in England marks 25 years of preserving the world’s plant diversity
On Oct. 20, 2025, the Millennium Seed Bank at the Royal Botanic Gardens Kew, located deep underground beneath…
Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia
On Oct. 20, 2025, Merck announced the start of construction for a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility…
Glaukos Announces FDA Approval of Epioxa™
On Oct. 20, 2025, Glaukos announced today the U.S. Food and Drug Administration (FDA) approved its Epioxa™ HD…
The Jackson Laboratory acquires New York Stem Cell Foundation to transform biomedical research and accelerate precision therapies for patients
On Oct. 20, 2025, The Jackson Laboratory (JAX), a global leader in genetics and genomic medicine, announced it…